Lindbrook Capital, LLC
- SEC CIK
- 0001767045
- Latest filing
- May 5, 2025
PCRX holding history
Pacira BioSciences, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCRX overviewAll 13F holders of PCRXFull Q1 2025 holdings
- Shares (Q1 2025)
- 527
- Value
- $13.1K
- % of portfolio
- <0.1%
- Quarters held
- 10
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 527 | $13.1K | <0.1% | −4−0.8% | Reduced | Holders |
| Q4 2024 | 531 | $10.0K | <0.1% | +413+350.0% | Added | Holders |
| Q3 2024 | 118 | $1.78K | <0.1% | −56−32.2% | Reduced | Holders |
| Q2 2024 | 174 | $4.98K | <0.1% | +30+20.8% | Added | Holders |
| Q1 2024 | 144 | $4.21K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 144 | $4.86K | <0.1% | +124+620.0% | Added | Holders |
| Q3 2023 | 20 | $614 | <0.1% | +20 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −76−100.0% | Sold out | Holders |
| Q1 2023 | 76 | $3.10K | <0.1% | +76 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −15−100.0% | Sold out | Holders |
| Q3 2022 | 15 | $1.00K | <0.1% | +7+87.5% | Added | Holders |
| Q2 2022 | 8 | $0 | 0.0% | +8 | New | Holders |